epiglottitis
EPIGLOTTITIS
Treatment Guideline Chart
Epiglottitis is the inflammation of the epiglottis and supraglottic tissues (aryepilottic folds, arytenoid, uvula).
It is often characterized by an acute, rapidly progressing respiratory disease.
It is a medical emergency in children requiring immediate treatment and typically artificial airway placement.
H. influenzae type B is the most common etiologic agent in children.

Epiglottitis Management

Airway Management

  • A physician well-versed in airway management & use of intubation apparatus should accompany patients w/ suspected epiglottitis at all times
  • In patients w/ epiglottitis, an airway should be established to prevent airway obstruction, regardless of the degree of respiratory distress, by either nasotracheal intubation or tracheostomy
    • If possible, the procedure should be done in either an operating room or intensive care unit (ICU)
    • Using a nasotracheal tube that is 0.5-1 mm smaller than that estimated by age is recommended for easier intubation & lesser long-term sequelae
  • Bag-valve-mask ventilation may be done if there is an delay in intubation
  • If intubation & ventilation both can not be performed, cricothyroidotomy may be considered if airway obstruction is imminent
  • The duration of intubation depends on the patient’s clinical progress & duration of epiglottic swelling
    • Reduction in swelling can be determined by direct laryngoscopy or flexible fiber optic laryngoscopy
    • Patient should improve sufficiently & should be able to handle secretions adequately
  • The tube should be removed as soon as possible, which is usually within a few days
    • Intubation is required for <24 hours in most cases

Prevention

Haemophilus influenzae type B (Hib) vaccine

  • Studies have shown a decrease in the incidence of epiglottitis because of increased H influenzae type b vaccination

Please refer to Pneumonia - Community-Acquired Disease Management Chart for details on vaccination against S pneumonia

Further Evaluation

  • Antibiotic prophylaxis w/ Rifampicin should be given to the following household members:
    • Children ≤4 years of age w/o or w/ incomplete vaccination against H influenzae type b
    • There is 1 or more contact <48 months of age in the household who is incompletely immunized
    • Within the household of an immunocompromised child
  • Chemoprophylaxis w/ Rifampin, Ceftriaxone, or Ciprofloxacin is recommended for older children & adults who came in contact w/ patients infected w/ H influenzae type b or meningococcal epiglottitis
Editor's Recommendations
Special Reports